With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
5 days 3 hours ago
5 days 14 hours ago
2 weeks 17 hours ago
7 weeks 1 day ago
9 weeks 4 days ago
14 weeks 5 days ago
26 weeks 5 days ago
28 weeks 5 days ago
29 weeks 5 days ago
38 weeks 3 days ago